Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates

Haemonetics (HAE) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $0.99 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.75%. A quarter ago, it was expected that this provider blood management systems for health care providers and blood collectors would post earnings of $1.03 per share when it actually produced earnings of $1.02, delive ...